These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6523766)

  • 1. [Significance of prognostic indicators in multiple myeloma. I. Clinical, biochemical and radiographic indicators].
    Scudla V; Wiedermann B; Wiedermann D; Indrák K
    Vnitr Lek; 1984 Dec; 30(12):1145-55. PubMed ID: 6523766
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of clinical and biochemical variables in the prognosis of multiple myeloma].
    Galesić K; Sabljar-Matovinović M; Jaksić B
    Lijec Vjesn; 1987; 109(8-9):310-3. PubMed ID: 3669898
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of prognostic indicators in multiple myeloma. II. Selected hematologic indicators].
    Scudla V; Wiedermann B; Wiedermann D; Indrák K; Spidlová A
    Vnitr Lek; 1984 Dec; 30(12):1156-65. PubMed ID: 6523767
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution to the evaluation of the relationship between angiogenic cytokines, selected biological parameters and prognostic factors in multiple myeloma].
    Scudla V; Pika T; Budíková M; Ordeltová M; Minarík J; Zemanová M; Bacovský J; Srovnalík K;
    Cas Lek Cesk; 2006; 145(12):929-35. PubMed ID: 17323615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Light chain myeloma: clinical study and prognostic factors ].
    Redón J; Caballero M; Herranz C
    Med Clin (Barc); 1982 Jun 16-30; 79(2):54-8. PubMed ID: 6811809
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relation of the soluble cytoadhesion molecules VCAM-1 and ICAM-1 to selected clinical and laboratory indicators in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Ordeltová M; Opíchalová D; Heincová V
    Vnitr Lek; 1999 Oct; 45(10):583-90. PubMed ID: 10951865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The wide variations of the clinical behavior and prognosis in multiple myeloma].
    Kanoh T; Hirashimizu K
    Rinsho Ketsueki; 1993 Apr; 34(4):439-43. PubMed ID: 8510330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease.
    Hungria VT; Latrilha MC; Rodrigues DG; Bydlowski SP; Chiattone CS; Maranhão RC
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.
    Scudla V; Ordeltova M; Minarik J; Dusek L; Zemanova M; Bacovsky J
    Neoplasma; 2006; 53(3):213-8. PubMed ID: 16652190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma.
    Andrade VC; Vettore AL; Regis Silva MR; Felix RS; Almeida MS; de Carvalho F; Zago MA; Caballero OL; Simpson AJ; Colleoni GW
    Exp Hematol; 2009 Apr; 37(4):446-9. PubMed ID: 19211183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperammonemic encephalopathy in multiple myeloma.
    Pérez Retortillo JA; Marco F; Amutio E; Conde E; Iriondo A; Zubizarreta A
    Haematologica; 1998 Oct; 83(10):956-7. PubMed ID: 9830811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of telomerase activity in multiple myeloma.
    Shiratsuchi M; Muta K; Abe Y; Motomura S; Taguchi F; Takatsuki H; Uike N; Umemura T; Nawata H; Nishimura J
    Cancer; 2002 Apr; 94(8):2232-8. PubMed ID: 12001122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The bromodeoxyuridine index in multiple myeloma. I. Relation with selected laboratory indicators of the disease].
    Scudla V; Ordeltová M; Bacovský J; Spidlová A; Budíková M; Kubalová D; Zivná J
    Vnitr Lek; 1996 Jul; 42(7):458-62. PubMed ID: 8928421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aggressive multiple myeloma].
    Kanoh T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):427-30. PubMed ID: 9851180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.